A recent study demonstrated that HPV-positive HNSCC with mutations of either CYLD or TRAF3, which has similar function to CYLD, demonstrated increased NF-κB activity, harbored HPV DNA in episomal form rather than integrated genomic form, and correlated with improved patient survival [15]. The gene discussed is CYLD; the disease is head and neck squamous cell carcinoma.